US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Palisade Bio Inc.

2.01

-0.0900-4.29%

Post-market: 2.010.00000.00%18:19 EDT

Volume:1.62M

Turnover:3.32M

Market Cap:349.74M

PE:-9.98

High:2.10

Open:2.10

Low:2.00

Close:2.10

52wk High:2.86

52wk Low:0.5300

Shares:174.00M

Float Shares:130.00M

Volume Ratio:0.97

T/O Rate:1.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2015

EPS(LYR):-0.3014

ROE:-51.37%

ROA:-32.98%

PB:2.87

PE(LYR):-6.67

Loading ...

Overview Company News Filings

Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108

Palisade Bio Q1 FY26 net loss widens to $9.6 million; operating loss widens to $10.75 million

Palisade Bio Inc expected to post a loss of 4 cents a share - Earnings Preview

Palisade Bio Phase 1a/b data show PALI-2108 supports once-daily ulcerative colitis dosing

Palisade Bio Reports Additional Phase 1a/B Data Demonstrating Colon-Targeted Exposure and Sustained Ic90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis

THOMSON REUTERS

Palisade Bio announces annual shareholder meeting

Palisade Bio says PALI-2108 Phase 1 ulcerative colitis data set for DDW poster

Piper Sandler Reaffirms Their Buy Rating on Palisade Bio (PALI)

Palisade Bio Initiated at Outperform by Wolfe Research

Palisade Bio to present at Needham & Co. annual healthcare conference

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)

Palisade Bio partners with Iterative Health to advance PALI-2108

Palisade Bio sells 1.54 million shares in $3 million private placement to Iterative affiliate

Analysts Have Conflicting Sentiments on These Healthcare Companies: Palisade Bio (PALI) and Moderna (MRNA)

Palisade Bio reaction to PALI-2108 data ‘looks misaligned’, says Clear Street

Palisade Bio announces topline data from PALI-2108 trial

Palisade Bio reports positive Phase 1b PALI-2108 data in fibrostenotic Crohn’s disease

Palisade Bio Inc - Pali-2108 Shows Favorable Safety With No Serious Adverse Events After Two Weeks

THOMSON REUTERS

Palisade Bio Inc - Phase 1B Data Show 47.5% Ses-Cd Reduction; 40% Endoscopic Response and Remission

THOMSON REUTERS

Palisade Bio Inc - to Advance Pali-2108 Into Phase 2 Trial in Moderate to Severe Crohn's Disease

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PALI/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PALI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","market":"US","secType":"STK","nameCN":"Palisade Bio Inc.","latestPrice":2.01,"timestamp":1787601600000,"preClose":2.1,"halted":0,"volume":1618506,"hourTrading":{"tag":"盘后","latestPrice":2.01,"preClose":2.01,"latestTime":"18:19 EDT","volume":10078,"amount":20364.126824799998,"timestamp":1787609963173,"change":0,"changeRate":0,"amplitude":0.014925},"delay":0,"changeRate":-0.042857142857142996,"floatShares":130000000,"shares":174000000,"eps":-0.201475,"marketStatus":"Post-Mkt","change":-0.09,"latestTime":"08-24 19:22:00 EDT","open":2.1,"high":2.1,"low":2,"amount":3320386.4232792,"amplitude":0.047619,"askPrice":2.1,"askSize":600,"bidPrice":2,"bidSize":350,"shortable":3,"etf":0,"ttmEps":-0.201475,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1188187200000,"exchange":"NASDAQ","adjPreClose":2.1,"preHourTrading":{"tag":"盘前","latestPrice":2.1,"preClose":2.1,"latestTime":"09:22 EDT","volume":440678,"amount":925434.6847466,"timestamp":1787577725736,"change":0,"changeRate":0,"amplitude":0.037143},"postHourTrading":{"tag":"盘后","latestPrice":2.01,"preClose":2.01,"latestTime":"18:19 EDT","volume":10078,"amount":20364.126824799998,"timestamp":1787609963173,"change":0,"changeRate":0,"amplitude":0.014925},"volumeRatio":0.966184},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","floatShares":130000000,"roa":"-32.98%","roe":"-51.37%","lyrEps":-0.301438,"volumeRatio":0.966184,"shares":174000000,"dividePrice":0,"high":2.1,"amplitude":0.047619,"preClose":2.1,"low":2,"week52Low":0.53,"pbRate":"2.87","psRate":"699.48","week52High":2.855,"institutionHeld":0.9814,"latestPrice":2.01,"committee":-0.263158,"eps":-0.201475,"divideRate":0,"volume":1618506,"delay":0,"ttmEps":-0.201475,"open":2.1,"prevYearClose":2.35,"prevWeekClose":2.1,"prevMonthClose":1.895,"prevQuarterClose":2.09,"fiveDayClose":2.15,"twentyDayClose":2.03,"sixtyDayClose":2.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PALI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"PALI","fiscalQuarterEnding":"2026/06","expectedEps":-0.05,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2026-05-12","symbol":"PALI","fiscalQuarterEnding":"2026/03","expectedEps":-0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2026-03-20","symbol":"PALI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773979200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-10","symbol":"PALI","fiscalQuarterEnding":"2025/09","expectedEps":-0.32,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2025-08-11","symbol":"PALI","fiscalQuarterEnding":"2025/06","expectedEps":-0.48,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PALI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PALI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1784865600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PALI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PALI","date":"2026-08-21","current":-10.150143,"percent":0.176763,"low":-33.182614,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"high":5.714804,"avg":-3.731889,"sd":7.88063,"marketCap":358997349},"quantilePoints":[{"date":"2021-08-27","current":-0.68888,"twenty":-3.431237,"median":-2.990078,"eighty":-1.683951,"marketCap":28838584},{"date":"2021-09-03","current":-0.743337,"twenty":-3.431237,"median":-2.965569,"eighty":-1.659545,"marketCap":31118314},{"date":"2021-09-10","current":-0.816854,"twenty":-3.392023,"median":-2.932891,"eighty":-1.582669,"marketCap":34195950},{"date":"2021-09-17","current":-0.74606,"twenty":-3.375684,"median":-2.859364,"eighty":-1.503353,"marketCap":31232301},{"date":"2021-09-24","current":-0.658929,"twenty":-3.360979,"median":-2.373394,"eighty":-0.786902,"marketCap":27584733},{"date":"2021-10-01","current":-0.677989,"twenty":-3.351175,"median":-2.205609,"eighty":-0.760763,"marketCap":28382638},{"date":"2021-10-08","current":-0.756712,"twenty":-3.343006,"median":-2.123242,"eighty":-0.751505,"marketCap":31678255},{"date":"2021-10-15","current":-0.85246,"twenty":-3.3283,"median":-2.086634,"eighty":-0.753683,"marketCap":35686524},{"date":"2021-10-22","current":-0.80613,"twenty":-3.318497,"median":-2.056128,"eighty":-0.756215,"marketCap":33747039},{"date":"2021-10-29","current":-0.846283,"twenty":-3.303792,"median":-1.860887,"eighty":-0.76126,"marketCap":35427926},{"date":"2021-11-05","current":-0.880257,"twenty":-3.254774,"median":-1.683951,"eighty":-0.762791,"marketCap":36850215},{"date":"2021-11-12","current":-1.134957,"twenty":-3.236801,"median":-1.674799,"eighty":-0.764674,"marketCap":36242580},{"date":"2021-11-19","current":-1.045691,"twenty":-3.235167,"median":-1.659545,"eighty":-0.782546,"marketCap":33392040},{"date":"2021-11-26","current":-0.981929,"twenty":-3.220462,"median":-1.604634,"eighty":-0.786902,"marketCap":31355940},{"date":"2021-12-03","current":-0.786393,"twenty":-3.210658,"median":-1.558874,"eighty":-0.786902,"marketCap":25111900},{"date":"2021-12-10","current":-0.892663,"twenty":-3.210658,"median":-1.507014,"eighty":-0.786902,"marketCap":28505400},{"date":"2021-12-17","current":-0.807647,"twenty":-3.195953,"median":-1.139207,"eighty":-0.786902,"marketCap":25790600},{"date":"2021-12-23","current":-0.709879,"twenty":-3.179613,"median":-1.06907,"eighty":-0.786393,"marketCap":22668580},{"date":"2021-12-31","current":-0.552601,"twenty":-3.146935,"median":-0.994681,"eighty":-0.758986,"marketCap":17646200},{"date":"2022-01-07","current":-0.565353,"twenty":-3.109355,"median":-0.984055,"eighty":-0.751505,"marketCap":18053420},{"date":"2022-01-14","current":-0.552601,"twenty":-3.101185,"median":-0.973427,"eighty":-0.743337,"marketCap":17646200},{"date":"2022-01-21","current":-0.448457,"twenty":-3.094649,"median":-0.914232,"eighty":-0.729723,"marketCap":14320570},{"date":"2022-01-28","current":-0.467585,"twenty":-3.088114,"median":-0.892637,"eighty":-0.708328,"marketCap":14931400},{"date":"2022-02-04","current":-0.393367,"twenty":-3.084846,"median":-0.884161,"eighty":-0.689425,"marketCap":12561379},{"date":"2022-02-11","current":-0.429328,"twenty":-3.068506,"median":-0.872535,"eighty":-0.671031,"marketCap":13709740},{"date":"2022-02-18","current":-0.403016,"twenty":-3.042364,"median":-0.855548,"eighty":-0.659474,"marketCap":12869509},{"date":"2022-02-25","current":-0.391071,"twenty":-2.990078,"median":-0.850155,"eighty":-0.641867,"marketCap":12488080},{"date":"2022-03-04","current":-0.393154,"twenty":-2.990078,"median":-0.849371,"eighty":-0.599359,"marketCap":12554592},{"date":"2022-03-11","current":-0.442081,"twenty":-2.990078,"median":-0.849371,"eighty":-0.582356,"marketCap":14116960},{"date":"2022-03-18","current":-0.602849,"twenty":-2.965569,"median":-0.844549,"eighty":-0.565353,"marketCap":16045436},{"date":"2022-03-25","current":-0.801515,"twenty":-2.965569,"median":-0.837017,"eighty":-0.565353,"marketCap":21333136},{"date":"2022-04-01","current":-0.712458,"twenty":-2.932891,"median":-0.829295,"eighty":-0.573855,"marketCap":18962788},{"date":"2022-04-08","current":-0.650735,"twenty":-2.883873,"median":-0.816854,"eighty":-0.582356,"marketCap":17319954},{"date":"2022-04-14","current":-0.637102,"twenty":-2.870802,"median":-0.811898,"eighty":-0.585757,"marketCap":16957108},{"date":"2022-04-22","current":-0.615317,"twenty":-2.854463,"median":-0.806889,"eighty":-0.593409,"marketCap":16377284},{"date":"2022-04-29","current":-0.534344,"twenty":-2.831588,"median":-0.794895,"eighty":-0.573762,"marketCap":14222091},{"date":"2022-05-06","current":-0.422789,"twenty":-2.464052,"median":-0.788264,"eighty":-0.559402,"marketCap":11252961},{"date":"2022-05-13","current":-0.412841,"twenty":-2.329465,"median":-0.786902,"eighty":-0.547771,"marketCap":11060415},{"date":"2022-05-20","current":-0.424683,"twenty":-2.235505,"median":-0.786393,"eighty":-0.513494,"marketCap":11377678},{"date":"2022-05-27","current":-0.418149,"twenty":-2.200118,"median":-0.76512,"eighty":-0.503186,"marketCap":11202636},{"date":"2022-06-03","current":-0.444937,"twenty":-2.152528,"median":-0.762397,"eighty":-0.476087,"marketCap":11920305},{"date":"2022-06-10","current":-0.438567,"twenty":-2.123242,"median":-0.758562,"eighty":-0.466914,"marketCap":11749640},{"date":"2022-06-17","current":-0.367514,"twenty":-2.11226,"median":-0.754228,"eighty":-0.451634,"marketCap":9846067},{"date":"2022-06-24","current":-0.366126,"twenty":-2.102498,"median":-0.751505,"eighty":-0.445495,"marketCap":9808871},{"date":"2022-07-01","current":-0.325781,"twenty":-2.089075,"median":-0.746385,"eighty":-0.44007,"marketCap":8727991},{"date":"2022-07-08","current":-0.400264,"twenty":-2.071991,"median":-0.743612,"eighty":-0.43499,"marketCap":10723461},{"date":"2022-07-15","current":-0.383848,"twenty":-2.061009,"median":-0.737891,"eighty":-0.428094,"marketCap":10283670},{"date":"2022-07-22","current":-0.363839,"twenty":-2.043925,"median":-0.728361,"eighty":-0.424683,"marketCap":9747606},{"date":"2022-07-29","current":-0.315572,"twenty":-1.981692,"median":-0.721554,"eighty":-0.420835,"marketCap":8454489},{"date":"2022-08-05","current":-0.423458,"twenty":-1.901155,"median":-0.712458,"eighty":-0.418084,"marketCap":11344857},{"date":"2022-08-12","current":-0.570101,"twenty":-1.792553,"median":-0.709879,"eighty":-0.416508,"marketCap":15273575},{"date":"2022-08-19","current":4.414871,"twenty":-1.766928,"median":-0.701936,"eighty":-0.411475,"marketCap":11527227},{"date":"2022-08-26","current":4.512979,"twenty":-1.683951,"median":-0.68888,"eighty":-0.405749,"marketCap":11783387},{"date":"2022-09-02","current":4.029939,"twenty":-1.682731,"median":-0.683343,"eighty":-0.400558,"marketCap":10522170},{"date":"2022-09-09","current":4.038124,"twenty":-1.677849,"median":-0.676931,"eighty":-0.398303,"marketCap":10543542},{"date":"2022-09-16","current":3.819847,"twenty":-1.671748,"median":-0.667097,"eighty":-0.394592,"marketCap":9973621},{"date":"2022-09-23","current":3.113175,"twenty":-1.671748,"median":-0.660291,"eighty":-0.391921,"marketCap":8128501},{"date":"2022-09-30","current":2.701177,"twenty":-1.659545,"median":-0.650735,"eighty":-0.39079,"marketCap":7052774},{"date":"2022-10-07","current":2.709363,"twenty":-1.647343,"median":-0.642122,"eighty":-0.38563,"marketCap":7074146},{"date":"2022-10-14","current":2.589311,"twenty":-1.604634,"median":-0.637102,"eighty":-0.373068,"marketCap":6760690},{"date":"2022-10-21","current":2.837601,"twenty":-1.58633,"median":-0.630286,"eighty":-0.367514,"marketCap":7408975},{"date":"2022-10-28","current":2.589311,"twenty":-1.568026,"median":-0.61381,"eighty":-0.365524,"marketCap":6760690},{"date":"2022-11-04","current":2.335563,"twenty":-1.549723,"median":-0.605735,"eighty":-0.361316,"marketCap":6098156},{"date":"2022-11-11","current":2.23461,"twenty":-1.53752,"median":-0.602301,"eighty":-0.35118,"marketCap":5834568},{"date":"2022-11-18","current":-0.398957,"twenty":-1.507014,"median":-0.597644,"eighty":-0.35538,"marketCap":3776927},{"date":"2022-11-25","current":-0.610649,"twenty":-1.492371,"median":-0.60083,"eighty":-0.357408,"marketCap":5781011},{"date":"2022-12-02","current":-0.69044,"twenty":-1.212508,"median":-0.602849,"eighty":-0.359061,"marketCap":6536396},{"date":"2022-12-09","current":-0.498289,"twenty":-1.136657,"median":-0.60083,"eighty":-0.35977,"marketCap":4717305},{"date":"2022-12-16","current":-0.381045,"twenty":-1.083947,"median":-0.59593,"eighty":-0.361028,"marketCap":3607351},{"date":"2022-12-23","current":-0.311024,"twenty":-1.067795,"median":-0.594423,"eighty":-0.354976,"marketCap":2944461},{"date":"2022-12-30","current":-0.846766,"twenty":-1.054193,"median":-0.590172,"eighty":-0.352489,"marketCap":8016335},{"date":"2023-01-06","current":-0.785441,"twenty":-1.058443,"median":-0.595109,"eighty":-0.354169,"marketCap":7435768},{"date":"2023-01-13","current":-1.118311,"twenty":-1.058443,"median":-0.597622,"eighty":-0.356394,"marketCap":10587051},{"date":"2023-01-20","current":-0.996847,"twenty":-1.067829,"median":-0.602301,"eighty":-0.358201,"marketCap":9437147},{"date":"2023-01-27","current":-0.938209,"twenty":-1.066328,"median":-0.605735,"eighty":-0.359453,"marketCap":8882021},{"date":"2023-02-03","current":-1.143442,"twenty":-1.078731,"median":-0.610649,"eighty":-0.360164,"marketCap":10824963},{"date":"2023-02-10","current":-0.967528,"twenty":-1.070566,"median":-0.618682,"eighty":-0.361739,"marketCap":9159584},{"date":"2023-02-17","current":-0.967528,"twenty":-1.067829,"median":-0.630252,"eighty":-0.363512,"marketCap":9159584},{"date":"2023-02-24","current":-0.904701,"twenty":-1.066945,"median":-0.631818,"eighty":-0.363839,"marketCap":8564806},{"date":"2023-03-03","current":-0.900513,"twenty":-1.063862,"median":-0.637102,"eighty":-0.363839,"marketCap":8525154},{"date":"2023-03-10","current":-0.846063,"twenty":-1.045691,"median":-0.641867,"eighty":-0.365524,"marketCap":8009679},{"date":"2023-03-17","current":-0.795802,"twenty":-1.030354,"median":-0.647255,"eighty":-0.365881,"marketCap":7533857},{"date":"2023-03-24","current":-0.517989,"twenty":-1.005224,"median":-0.646473,"eighty":-0.365962,"marketCap":7386522},{"date":"2023-03-31","current":-1.111781,"twenty":-1.005224,"median":-0.644425,"eighty":-0.366126,"marketCap":15853999},{"date":"2023-04-06","current":-0.688546,"twenty":-1.01025,"median":-0.647255,"eighty":-0.367236,"marketCap":9818669},{"date":"2023-04-14","current":-0.713644,"twenty":-1.001873,"median":-0.652987,"eighty":-0.368102,"marketCap":10176564},{"date":"2023-04-21","current":-0.654174,"twenty":-1.001035,"median":-0.65541,"eighty":-0.369295,"marketCap":9328517},{"date":"2023-04-28","current":-0.737945,"twenty":-1.001035,"median":-0.654615,"eighty":-0.371189,"marketCap":10523092},{"date":"2023-05-05","current":-0.628469,"twenty":-0.997685,"median":-0.65541,"eighty":-0.372642,"marketCap":8961974},{"date":"2023-05-12","current":-0.656852,"twenty":-0.995114,"median":-0.654615,"eighty":-0.373035,"marketCap":9366708},{"date":"2023-05-19","current":-0.732361,"twenty":-0.993063,"median":-0.656852,"eighty":-0.374309,"marketCap":9077612},{"date":"2023-05-25","current":-0.676384,"twenty":-0.991322,"median":-0.659918,"eighty":-0.377706,"marketCap":8383782},{"date":"2023-06-02","current":-0.778028,"twenty":-0.988731,"median":-0.663013,"eighty":-0.380276,"marketCap":9643654},{"date":"2023-06-09","current":-0.869878,"twenty":-0.98448,"median":-0.667097,"eighty":-0.382166,"marketCap":10782141},{"date":"2023-06-15","current":-0.875281,"twenty":-0.981929,"median":-0.67307,"eighty":-0.384204,"marketCap":10849110},{"date":"2023-06-23","current":-0.923908,"twenty":-0.981929,"median":-0.674471,"eighty":-0.385274,"marketCap":11451839},{"date":"2023-06-30","current":-0.864475,"twenty":-0.980827,"median":-0.677186,"eighty":-0.386075,"marketCap":10715171},{"date":"2023-07-07","current":-0.950923,"twenty":-0.97876,"median":-0.681631,"eighty":-0.386553,"marketCap":11786688},{"date":"2023-07-14","current":-1.102206,"twenty":-0.981929,"median":-0.685714,"eighty":-0.387278,"marketCap":13661843},{"date":"2023-07-21","current":-1.085997,"twenty":-0.98788,"median":-0.687352,"eighty":-0.387446,"marketCap":13460933},{"date":"2023-07-28","current":-1.167042,"twenty":-0.998522,"median":-0.69044,"eighty":-0.387685,"marketCap":14465481},{"date":"2023-08-04","current":-1.123818,"twenty":-1.015276,"median":-0.695051,"eighty":-0.389582,"marketCap":13929722},{"date":"2023-08-11","current":-0.372805,"twenty":-1.046685,"median":-0.69506,"eighty":-0.389582,"marketCap":4620917},{"date":"2023-08-18","current":-0.316168,"twenty":-1.036489,"median":-0.691021,"eighty":-0.386075,"marketCap":4250561},{"date":"2023-08-25","current":-0.316168,"twenty":-1.015276,"median":-0.688546,"eighty":-0.377706,"marketCap":4250561},{"date":"2023-09-01","current":-0.347683,"twenty":-1.002711,"median":-0.685385,"eighty":-0.372322,"marketCap":4674246},{"date":"2023-09-08","current":-0.397658,"twenty":-1.001035,"median":-0.683343,"eighty":-0.370372,"marketCap":5346109},{"date":"2023-09-15","current":-0.424944,"twenty":-1.001035,"median":-0.677186,"eighty":-0.371839,"marketCap":5712941},{"date":"2023-09-19","current":-0.414479,"twenty":-1.001035,"median":-0.676384,"eighty":-0.37208,"marketCap":5572256},{"date":"2023-09-29","current":-0.368654,"twenty":-1.001035,"median":-0.674471,"eighty":-0.368654,"marketCap":4956181},{"date":"2023-10-06","current":-0.39054,"twenty":-0.996847,"median":-0.66982,"eighty":-0.369556,"marketCap":5250426},{"date":"2023-10-13","current":-0.378092,"twenty":-0.995114,"median":-0.666828,"eighty":-0.371189,"marketCap":5083074},{"date":"2023-10-17","current":-0.411059,"twenty":-0.994276,"median":-0.664374,"eighty":-0.371839,"marketCap":5526280},{"date":"2023-11-02","current":-0.376177,"twenty":-0.993063,"median":-0.66128,"eighty":-0.372563,"marketCap":5057328},{"date":"2023-11-10","current":-0.355659,"twenty":-0.990876,"median":-0.656852,"eighty":-0.371023,"marketCap":4781473},{"date":"2023-11-17","current":-0.36942,"twenty":-0.98703,"median":-0.65541,"eighty":-0.369529,"marketCap":4820558},{"date":"2023-11-24","current":-0.413213,"twenty":-0.98448,"median":-0.654174,"eighty":-0.370164,"marketCap":5392020},{"date":"2023-12-01","current":-0.441467,"twenty":-0.981929,"median":-0.652797,"eighty":-0.371138,"marketCap":5760705},{"date":"2023-12-08","current":-0.431578,"twenty":-0.981562,"median":-0.649739,"eighty":-0.371431,"marketCap":5631665},{"date":"2023-12-15","current":-0.416816,"twenty":-0.97876,"median":-0.646473,"eighty":-0.371839,"marketCap":5439027},{"date":"2023-12-22","current":-0.420347,"twenty":-0.973249,"median":-0.644586,"eighty":-0.372825,"marketCap":5485113},{"date":"2023-12-29","current":-0.461881,"twenty":-0.972713,"median":-0.642377,"eighty":-0.372883,"marketCap":6027080},{"date":"2024-01-05","current":-0.385997,"twenty":-0.972207,"median":-0.641518,"eighty":-0.372969,"marketCap":5036876},{"date":"2024-01-12","current":-0.376548,"twenty":-0.970041,"median":-0.637102,"eighty":-0.373217,"marketCap":4913573},{"date":"2024-01-19","current":-0.376548,"twenty":-0.967528,"median":-0.633446,"eighty":-0.373143,"marketCap":4913573},{"date":"2024-01-26","current":-0.363049,"twenty":-0.96669,"median":-0.630286,"eighty":-0.372825,"marketCap":4737426},{"date":"2024-02-02","current":-0.416981,"twenty":-0.962806,"median":-0.628469,"eighty":-0.372825,"marketCap":5441185},{"date":"2024-02-09","current":-0.319738,"twenty":-0.96037,"median":-0.623231,"eighty":-0.371427,"marketCap":4172255},{"date":"2024-02-16","current":-0.314051,"twenty":-0.957505,"median":-0.61381,"eighty":-0.369425,"marketCap":4098049},{"date":"2024-02-23","current":-0.300332,"twenty":-0.950923,"median":-0.60922,"eighty":-0.368249,"marketCap":3919026},{"date":"2024-03-01","current":-0.285759,"twenty":-0.94552,"median":-0.603229,"eighty":-0.365962,"marketCap":3728872},{"date":"2024-03-08","current":-0.278224,"twenty":-0.942397,"median":-0.599359,"eighty":-0.363839,"marketCap":3630548},{"date":"2024-03-15","current":-0.261235,"twenty":-0.940117,"median":-0.595519,"eighty":-0.363404,"marketCap":3408857},{"date":"2024-03-22","current":-0.277087,"twenty":-0.938209,"median":-0.593738,"eighty":-0.36253,"marketCap":3615707},{"date":"2024-03-28","current":-0.410438,"twenty":-0.938209,"median":-0.582356,"eighty":-0.361028,"marketCap":5048382},{"date":"2024-04-05","current":-0.398186,"twenty":-0.938209,"median":-0.571746,"eighty":-0.361914,"marketCap":4897684},{"date":"2024-04-12","current":-0.303182,"twenty":-0.931507,"median":-0.565353,"eighty":-0.361028,"marketCap":3729136},{"date":"2024-04-19","current":-0.350943,"twenty":-0.929832,"median":-0.559354,"eighty":-0.359061,"marketCap":4316603},{"date":"2024-04-26","current":-0.431238,"twenty":-0.929832,"median":-0.552601,"eighty":-0.357464,"marketCap":5304228},{"date":"2024-05-03","current":-0.504611,"twenty":-0.929832,"median":-0.549758,"eighty":-0.359061,"marketCap":6206713},{"date":"2024-05-10","current":-0.480384,"twenty":-0.929415,"median":-0.546835,"eighty":-0.35977,"marketCap":5908722},{"date":"2024-05-17","current":-0.407804,"twenty":-0.929311,"median":-0.543164,"eighty":-0.361028,"marketCap":5500050},{"date":"2024-05-24","current":-0.358259,"twenty":-0.924989,"median":-0.534344,"eighty":-0.35977,"marketCap":4831834},{"date":"2024-05-31","current":-0.320072,"twenty":-0.923908,"median":-0.527464,"eighty":-0.358121,"marketCap":4316813},{"date":"2024-06-07","current":-0.325627,"twenty":-0.918102,"median":-0.520417,"eighty":-0.352702,"marketCap":4391725},{"date":"2024-06-14","current":-0.315212,"twenty":-0.913389,"median":-0.514587,"eighty":-0.349811,"marketCap":4251265},{"date":"2024-06-21","current":-0.330487,"twenty":-0.911478,"median":-0.507968,"eighty":-0.342356,"marketCap":4457273},{"date":"2024-06-28","current":-0.317295,"twenty":-0.910184,"median":-0.505842,"eighty":-0.339575,"marketCap":4279357},{"date":"2024-07-05","current":-0.30202,"twenty":-0.907214,"median":-0.504098,"eighty":-0.335275,"marketCap":4073348},{"date":"2024-07-12","current":-0.31174,"twenty":-0.904701,"median":-0.501591,"eighty":-0.330597,"marketCap":4204444},{"date":"2024-07-15","current":-0.315212,"twenty":-0.904701,"median":-0.49994,"eighty":-0.330487,"marketCap":4251265},{"date":"2024-08-02","current":-0.253419,"twenty":-0.904701,"median":-0.498289,"eighty":-0.329742,"marketCap":3417867},{"date":"2024-08-09","current":-0.252725,"twenty":-0.902443,"median":-0.487711,"eighty":-0.32575,"marketCap":3408503},{"date":"2024-08-16","current":-0.310036,"twenty":-0.900786,"median":-0.476087,"eighty":-0.322579,"marketCap":4394446},{"date":"2024-08-23","current":-0.300008,"twenty":-0.900513,"median":-0.47231,"eighty":-0.321132,"marketCap":4252308},{"date":"2024-08-30","current":-0.300843,"twenty":-0.897617,"median":-0.467585,"eighty":-0.319624,"marketCap":4264153},{"date":"2024-09-06","current":-0.306693,"twenty":-0.894355,"median":-0.465907,"eighty":-0.318303,"marketCap":4347067},{"date":"2024-09-13","current":-0.311707,"twenty":-0.892632,"median":-0.462608,"eighty":-0.317049,"marketCap":4418136},{"date":"2024-09-20","current":-0.320064,"twenty":-0.892326,"median":-0.459208,"eighty":-0.317065,"marketCap":4536585},{"date":"2024-09-27","current":-0.281623,"twenty":-0.890568,"median":-0.455058,"eighty":-0.316168,"marketCap":3991721},{"date":"2024-10-04","current":-0.297501,"twenty":-0.888577,"median":-0.448457,"eighty":-0.315212,"marketCap":4216773},{"date":"2024-10-11","current":-0.290815,"twenty":-0.887947,"median":-0.444099,"eighty":-0.313361,"marketCap":4122014},{"date":"2024-10-18","current":-0.298336,"twenty":-0.885675,"median":-0.442122,"eighty":-0.312157,"marketCap":4228618},{"date":"2024-10-25","current":-0.289144,"twenty":-0.881819,"median":-0.442081,"eighty":-0.31174,"marketCap":4098325},{"date":"2024-10-31","current":-0.259059,"twenty":-0.880257,"median":-0.44122,"eighty":-0.311068,"marketCap":3671909},{"date":"2024-11-08","current":-0.212262,"twenty":-0.878267,"median":-0.439544,"eighty":-0.310352,"marketCap":3008596},{"date":"2024-11-15","current":-0.220644,"twenty":-0.87312,"median":-0.438648,"eighty":-0.309383,"marketCap":3103355},{"date":"2024-11-22","current":-0.230645,"twenty":-0.869878,"median":-0.434565,"eighty":-0.307597,"marketCap":3244019},{"date":"2024-11-29","current":-0.232535,"twenty":-0.868865,"median":-0.433153,"eighty":-0.30673,"marketCap":3270609},{"date":"2024-12-06","current":-0.165421,"twenty":-0.864746,"median":-0.431408,"eighty":-0.304339,"marketCap":2326653},{"date":"2024-12-13","current":-0.223083,"twenty":-0.864475,"median":-0.429318,"eighty":-0.30202,"marketCap":3137657},{"date":"2024-12-20","current":-0.170148,"twenty":-0.864475,"median":-0.427619,"eighty":-0.300848,"marketCap":2393128},{"date":"2024-12-27","current":-0.167312,"twenty":-0.864475,"median":-0.427376,"eighty":-0.300008,"marketCap":2353243},{"date":"2025-01-03","current":-0.175819,"twenty":-0.862276,"median":-0.425615,"eighty":-0.298713,"marketCap":2472899},{"date":"2025-01-10","current":-0.189998,"twenty":-0.858019,"median":-0.424813,"eighty":-0.297501,"marketCap":2672327},{"date":"2025-01-17","current":-0.156914,"twenty":-0.853695,"median":-0.424683,"eighty":-0.296397,"marketCap":2206996},{"date":"2025-01-24","current":-0.139899,"twenty":-0.851577,"median":-0.423458,"eighty":-0.29497,"marketCap":1967683},{"date":"2025-01-31","current":-0.281219,"twenty":-0.850213,"median":-0.422628,"eighty":-0.294391,"marketCap":3955351},{"date":"2025-02-07","current":-0.255654,"twenty":-0.850155,"median":-0.421689,"eighty":-0.291697,"marketCap":3595774},{"date":"2025-02-14","current":-0.202557,"twenty":-0.849841,"median":-0.420673,"eighty":-0.288648,"marketCap":2848959},{"date":"2025-02-21","current":-0.192724,"twenty":-0.849371,"median":-0.420347,"eighty":-0.287568,"marketCap":2710660},{"date":"2025-02-28","current":-0.162045,"twenty":-0.849371,"median":-0.418149,"eighty":-0.286746,"marketCap":2279167},{"date":"2025-03-07","current":-0.164602,"twenty":-0.849371,"median":-0.417423,"eighty":-0.2853,"marketCap":2315125},{"date":"2025-03-14","current":-0.180433,"twenty":-0.84915,"median":-0.416981,"eighty":-0.283159,"marketCap":2537786},{"date":"2025-03-21","current":-0.154081,"twenty":-0.847966,"median":-0.416696,"eighty":-0.281643,"marketCap":2167145},{"date":"2025-03-28","current":-0.209966,"twenty":-0.846669,"median":-0.415332,"eighty":-0.281219,"marketCap":3031487},{"date":"2025-04-04","current":-0.19611,"twenty":-0.846239,"median":-0.413798,"eighty":-0.278423,"marketCap":2831440},{"date":"2025-04-11","current":-0.207073,"twenty":-0.846031,"median":-0.412841,"eighty":-0.273332,"marketCap":2989719},{"date":"2025-04-17","current":-0.213255,"twenty":-0.845904,"median":-0.412325,"eighty":-0.26877,"marketCap":3078975},{"date":"2025-04-25","current":-0.223974,"twenty":-0.843194,"median":-0.411077,"eighty":-0.265745,"marketCap":3233733},{"date":"2025-05-02","current":-0.237708,"twenty":-0.842863,"median":-0.410438,"eighty":-0.261235,"marketCap":3432021},{"date":"2025-05-09","current":-0.232927,"twenty":-0.841653,"median":-0.409293,"eighty":-0.256637,"marketCap":3362994},{"date":"2025-05-16","current":-0.227545,"twenty":-0.837686,"median":-0.408074,"eighty":-0.254212,"marketCap":2990163},{"date":"2025-05-23","current":-0.253106,"twenty":-0.837017,"median":-0.406762,"eighty":-0.253106,"marketCap":3326062},{"date":"2025-05-30","current":-0.229953,"twenty":-0.836999,"median":-0.405958,"eighty":-0.25303,"marketCap":3021814},{"date":"2025-06-06","current":-0.248267,"twenty":-0.834541,"median":-0.404031,"eighty":-0.25303,"marketCap":3262477},{"date":"2025-06-13","current":-0.251807,"twenty":-0.833584,"median":-0.403377,"eighty":-0.251713,"marketCap":3308995},{"date":"2025-06-20","current":-0.233743,"twenty":-0.832633,"median":-0.402244,"eighty":-0.248442,"marketCap":3071611},{"date":"2025-06-27","current":-0.260493,"twenty":-0.831326,"median":-0.40021,"eighty":-0.248442,"marketCap":3423132},{"date":"2025-07-03","current":-0.26458,"twenty":-0.830227,"median":-0.398957,"eighty":-0.248384,"marketCap":3476843},{"date":"2025-07-11","current":-0.284651,"twenty":-0.828686,"median":-0.398125,"eighty":-0.249392,"marketCap":3740603},{"date":"2025-07-18","current":-0.272243,"twenty":-0.826515,"median":-0.397044,"eighty":-0.25092,"marketCap":3577551},{"date":"2025-07-25","current":-0.405081,"twenty":-0.821539,"median":-0.396608,"eighty":-0.251524,"marketCap":5323167},{"date":"2025-08-01","current":-0.372236,"twenty":-0.815036,"median":-0.397044,"eighty":-0.252174,"marketCap":4891558},{"date":"2025-08-08","current":-0.395461,"twenty":-0.812144,"median":-0.395817,"eighty":-0.252877,"marketCap":5196747},{"date":"2025-08-15","current":-0.627447,"twenty":-0.810198,"median":-0.395461,"eighty":-0.253231,"marketCap":7432108},{"date":"2025-08-22","current":-0.558928,"twenty":-0.807647,"median":-0.397351,"eighty":-0.253697,"marketCap":6620504},{"date":"2025-08-29","current":-0.523052,"twenty":-0.80704,"median":-0.398064,"eighty":-0.254153,"marketCap":6195551},{"date":"2025-09-05","current":-0.487099,"twenty":-0.805913,"median":-0.398303,"eighty":-0.25422,"marketCap":5769687},{"date":"2025-09-12","current":-0.448066,"twenty":-0.80487,"median":-0.400115,"eighty":-0.254324,"marketCap":5307346},{"date":"2025-09-19","current":-0.460384,"twenty":-0.803646,"median":-0.401734,"eighty":-0.25465,"marketCap":5453252},{"date":"2025-09-26","current":-0.595112,"twenty":-0.801115,"median":-0.403377,"eighty":-0.254938,"marketCap":7049104},{"date":"2025-10-03","current":-1.308785,"twenty":-0.803646,"median":-0.404031,"eighty":-0.255496,"marketCap":15502558},{"date":"2025-10-10","current":-17.134268,"twenty":-0.807647,"median":-0.405375,"eighty":-0.255717,"marketCap":202955405},{"date":"2025-10-17","current":-14.115373,"twenty":-0.8231,"median":-0.406668,"eighty":-0.255997,"marketCap":167196595},{"date":"2025-10-24","current":-14.44174,"twenty":-0.831813,"median":-0.407939,"eighty":-0.256145,"marketCap":171062412},{"date":"2025-10-31","current":-21.783452,"twenty":-0.837012,"median":-0.408905,"eighty":-0.256335,"marketCap":258024989},{"date":"2025-11-07","current":-18.639449,"twenty":-0.843128,"median":-0.410109,"eighty":-0.256874,"marketCap":220784269},{"date":"2025-11-14","current":-22.155248,"twenty":-0.846669,"median":-0.411059,"eighty":-0.257837,"marketCap":248714809},{"date":"2025-11-21","current":-31.058927,"twenty":-0.849371,"median":-0.411794,"eighty":-0.258027,"marketCap":348667511},{"date":"2025-11-28","current":-28.006126,"twenty":-0.850155,"median":-0.412678,"eighty":-0.258558,"marketCap":314396773},{"date":"2025-12-05","current":-23.891482,"twenty":-0.861726,"median":-0.413213,"eighty":-0.259059,"marketCap":268205778},{"date":"2025-12-12","current":-29.2007,"twenty":-0.864814,"median":-0.41472,"eighty":-0.260493,"marketCap":327807062},{"date":"2025-12-19","current":-22.165986,"twenty":-0.880257,"median":-0.416491,"eighty":-0.260967,"marketCap":248835360},{"date":"2025-12-26","current":-29.2007,"twenty":-0.887947,"median":-0.416816,"eighty":-0.261181,"marketCap":327807062},{"date":"2026-01-02","current":-31.191657,"twenty":-0.892326,"median":-0.416981,"eighty":-0.261426,"marketCap":350157543},{"date":"2026-01-09","current":-25.218787,"twenty":-0.900513,"median":-0.417423,"eighty":-0.261727,"marketCap":283106099},{"date":"2026-01-16","current":-23.22783,"twenty":-0.906377,"median":-0.418149,"eighty":-0.262544,"marketCap":260755617},{"date":"2026-01-23","current":-24.555134,"twenty":-0.920038,"median":-0.420347,"eighty":-0.263055,"marketCap":275655938},{"date":"2026-01-30","current":-21.369603,"twenty":-0.929624,"median":-0.420673,"eighty":-0.263704,"marketCap":239895168},{"date":"2026-02-06","current":-19.909568,"twenty":-0.934858,"median":-0.421689,"eighty":-0.26458,"marketCap":223504815},{"date":"2026-02-13","current":-23.095099,"twenty":-0.941485,"median":-0.422628,"eighty":-0.264682,"marketCap":259265585},{"date":"2026-02-20","current":-21.635064,"twenty":-0.957505,"median":-0.423311,"eighty":-0.264965,"marketCap":242875232},{"date":"2026-02-27","current":-24.555134,"twenty":-0.967528,"median":-0.423808,"eighty":-0.265539,"marketCap":275655938},{"date":"2026-03-06","current":-21.767795,"twenty":-0.97876,"median":-0.424683,"eighty":-0.265767,"marketCap":244365264},{"date":"2026-03-13","current":-26.944283,"twenty":-0.989581,"median":-0.425078,"eighty":-0.26587,"marketCap":302476516},{"date":"2026-03-20","current":-26.413361,"twenty":-1.000197,"median":-0.427376,"eighty":-0.266232,"marketCap":296516387},{"date":"2026-03-27","current":-19.375141,"twenty":-1.007872,"median":-0.427777,"eighty":-0.267535,"marketCap":325134241},{"date":"2026-04-02","current":-18.584319,"twenty":-1.048176,"median":-0.429318,"eighty":-0.267864,"marketCap":311863455},{"date":"2026-04-10","current":-19.754184,"twenty":-1.066945,"median":-0.431183,"eighty":-0.268594,"marketCap":331494969},{"date":"2026-04-17","current":-23.246086,"twenty":-1.085997,"median":-0.43285,"eighty":-0.26877,"marketCap":390092565},{"date":"2026-04-24","current":-21.650111,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":363310518},{"date":"2026-05-01","current":-19.95402,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":334848404},{"date":"2026-05-08","current":-19.85425,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":333174161},{"date":"2026-05-15","current":-12.54763,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":303037805},{"date":"2026-05-22","current":-13.934108,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":336522646},{"date":"2026-05-29","current":-14.280728,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":344893856},{"date":"2026-06-05","current":-13.379517,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":323128709},{"date":"2026-06-12","current":-12.339658,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":298015079},{"date":"2026-06-18","current":-12.20101,"twenty":-1.121615,"median":-0.435627,"eighty":-0.269184,"marketCap":294666595},{"date":"2026-06-26","current":-12.937079,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":312443406},{"date":"2026-07-02","current":-14.158915,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":341951949},{"date":"2026-07-10","current":-14.158915,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":341951949},{"date":"2026-07-17","current":-13.583933,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":328065576},{"date":"2026-07-24","current":-14.518278,"twenty":-1.117005,"median":-0.434565,"eighty":-0.269048,"marketCap":350630933},{"date":"2026-07-31","current":-14.087042,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":340216153},{"date":"2026-08-07","current":-15.021387,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":362781510},{"date":"2026-08-14","current":-11.730431,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":374681699},{"date":"2026-08-21","current":-11.23939,"twenty":-1.111781,"median":-0.434072,"eighty":-0.268912,"marketCap":358997349}],"updateTime":1787597798549},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PALI\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635240553","title":"Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2635240553","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635240553?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:15","pubTimestamp":1778616900,"startTime":"0","endTime":"0","summary":"Advancing potentially best-in-class once-daily oral, locally-activated PDE4 inhibitor prodrug for treatment of IBD Phase 2 Ulcerative Colitis (UC) trial expected to commence 3Q 2026  Strong balance sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293420/0/en/Palisade-Bio-Reports-First-Quarter-2026-Financial-Results-and-Highlights-Continued-Clinical-Progress-of-PALI-2108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4007","PRGS","LU2065732104.USD","BK4139","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247541","title":"Palisade Bio Q1 FY26 net loss widens to $9.6 million; operating loss widens to $10.75 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247541","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247541?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616317,"startTime":"0","endTime":"0","summary":"Palisade Bio posted a net loss of $9.6 million for the three months ended March 31, 2026, widening 330% year over year.Operating loss widened to $10.75 million as total operating expenses climbed to $10.75 million, up 365% year over year.Research and development expense rose to $6.4 million, up 573% year over year, due to higher employee-related costs, clinical trial activity, and CMC spending.General and administrative expense increased to $4.35 million, up 220% year over year, on higher employee-related costs and professional fees.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system ope","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDLb4JwGm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634689460","title":"Palisade Bio Inc  expected to post a loss of 4 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634689460","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634689460?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:51","pubTimestamp":1778277065,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc  expected to post a loss of4cents a share - Earnings Preview Palisade Bio Inc PALI.OQ PALI.O is expected to  show no change in quarterly revenue when it reports  results on May 11 (es","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2QC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633481339","title":"Palisade Bio Phase 1a/b data show PALI-2108 supports once-daily ulcerative colitis dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633481339","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633481339?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:30","pubTimestamp":1777984226,"startTime":"0","endTime":"0","summary":"Palisade Bio reported additional Phase 1a/b analyses for ulcerative colitis drug candidate PALI-2108, with results presented at Digestive Disease Week 2026.Data showed the oral therapy concentrated its activity in colon tissue, supporting a gut-targeted profile intended to limit broader systemic exposure.Findings also supported once-daily dosing, with drug activity sustained across the full dosing interval.Translational readouts were consistent with localized anti-inflammatory pathway effects in the colon, aligning with previously disclosed early signs of clinical benefit in the study.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL72vlsS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","BK4139","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4007","SG9999014013.SGD","PALI","BK4585","SG9999014021.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633948954","title":"Palisade Bio Reports Additional Phase 1a/B Data Demonstrating Colon-Targeted Exposure and Sustained Ic90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2633948954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633948954?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:30","pubTimestamp":1777984208,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41I0L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PALI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628658784","title":"Palisade Bio announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628658784","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628658784?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:33","pubTimestamp":1776457997,"startTime":"0","endTime":"0","summary":"Palisade Bio schedules 2026 annual stockholders meeting to be held virtually via live webcast on a date in 2026.Items for vote include election of four directors, auditor ratification for fiscal year ending Dec. 31, 2026.Shareholder ballot also covers amendment to increase authorized common stock to 450,000,000 shares.Additional proposals include approval of amended and restated 2021 equity incentive plan, amended and restated 2021 employee stock purchase plan.Advisory vote on executive pay planned, alongside approval of equity award grants to non-employee directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL5PLPhW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627212130","title":"Palisade Bio says PALI-2108 Phase 1 ulcerative colitis data set for DDW poster","url":"https://stock-news.laohu8.com/highlight/detail?id=2627212130","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627212130?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:44","pubTimestamp":1776354293,"startTime":"0","endTime":"0","summary":"Palisade Bio disclosed that Phase 1 translational findings for lead ulcerative colitis program PALI-2108 were selected for poster presentation at Digestive Disease Week 2026.Results will be presented May 5, 2026, with no prior presentation referenced.Data showed rapid improvement across clinical symptoms, tissue-level inflammation, and biomarkers, supporting gut-targeted PDE4 inhibition as a potential once-daily oral approach.Management plans one-on-one meetings with qualified investors during DDW 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDLc7GjMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4585","NDAQ","LU2095319765.USD","BK4112","BK4007","SG9999014021.USD","IE00BKPKM429.USD","LU2210150020.SGD","BK4139","BK4588","PALI","SG9999014039.USD","SG9999014013.SGD","LU2210149790.SGD","LU0314104364.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627943709","title":"Piper Sandler Reaffirms Their Buy Rating on Palisade Bio (PALI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627943709","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627943709?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:38","pubTimestamp":1776080321,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi reiterated a Buy rating on Palisade Bio today and set a price target of $25.00. According to TipRanks, Rahimi ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-palisade-bio-pali-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-palisade-bio-pali-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626629131","title":"Palisade Bio Initiated at Outperform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2626629131","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626629131?lang=en_us&edition=fundamental","pubTime":"2026-04-10 00:48","pubTimestamp":1775753280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PALI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 09, 2026 12:48 ET (16:48 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Palisade Bio Initiated at Outperform by Wolfe Research","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625448159","title":"Palisade Bio to present at Needham & Co. annual healthcare conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2625448159","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625448159?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:03","pubTimestamp":1775653427,"startTime":"0","endTime":"0","summary":"Palisade Bio will present at Needham & Co. 25th Annual Healthcare Conference on April 16, 2026, 2:15 p.m.-2:55 p.m. ET.Needham conference runs April 14-17, 2026 in virtual format.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief on April 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL5tH7y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624023618","title":"Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624023618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624023618?lang=en_us&edition=fundamental","pubTime":"2026-04-04 22:50","pubTimestamp":1775314206,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and Anapty...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-neumora-therapeutics-inc-nmra-palisade-bio-pali-and-anaptysbio-anab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-neumora-therapeutics-inc-nmra-palisade-bio-pali-and-anaptysbio-anab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4585","HCSG","BK4007","BK4588","LU0029874061.USD","XBI","NMRA","LU0128526141.USD","ANAB","BK4581","BK4137","PALI","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624950470","title":"Palisade Bio partners with Iterative Health to advance PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2624950470","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624950470?lang=en_us&edition=fundamental","pubTime":"2026-04-02 21:26","pubTimestamp":1775136362,"startTime":"0","endTime":"0","summary":"Palisade Bio ( ($PALI) ) has provided an announcement. On March 30, 2026, Palisade Bio, Inc. entered into a master services agreement with Iterativ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/palisade-bio-partners-with-iterative-health-to-advance-pali-2108?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/palisade-bio-partners-with-iterative-health-to-advance-pali-2108?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624509482","title":"Palisade Bio sells 1.54 million shares in $3 million private placement to Iterative affiliate","url":"https://stock-news.laohu8.com/highlight/detail?id=2624509482","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624509482?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:35","pubTimestamp":1775133323,"startTime":"0","endTime":"0","summary":"Palisade Bio sold 1,536,885 common shares in an unregistered private placement that raised USD 3 million.Iterative Health affiliate bought shares at USD 1.952 each, based on average Nasdaq closing price over prior five trading days.Sale closed March 27, 2026, relying on Securities Act exemption under Section 4.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL4KyVbB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624734516","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Palisade Bio (PALI) and Moderna (MRNA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624734516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624734516?lang=en_us&edition=fundamental","pubTime":"2026-04-01 21:00","pubTimestamp":1775048452,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Palisade Bio (PALI) and Moderna (MRNA). Palisade Bio (PALI) In a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-palisade-bio-pali-and-moderna-mrna-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-palisade-bio-pali-and-moderna-mrna-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","MRNY","BK4568","BK4137","LU0128526141.USD","BK4532","BK4551","LABU","PALI","BK4548","XLV","BK4139","HCSG","BK4501","LU0029874061.USD","MRNX","BK4534","BK4533","MRNA","BK4581","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624530028","title":"Palisade Bio reaction to PALI-2108 data ‘looks misaligned’, says Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2624530028","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624530028?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:38","pubTimestamp":1774989519,"startTime":"0","endTime":"0","summary":"Clear Street keeps a Buy rating and $12 price target on Palisade Bio (PALI), saying the decline in the stock price after the Phase 1B Clinical Stud...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palisade-bio-reaction-to-pali-2108-data-looks-misaligned-says-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palisade-bio-reaction-to-pali-2108-data-looks-misaligned-says-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PALI","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623329914","title":"Palisade Bio announces topline data from PALI-2108 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2623329914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623329914?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:19","pubTimestamp":1774901956,"startTime":"0","endTime":"0","summary":"Palisade Bio (PALI) announced topline data from its Phase 1b clinical study evaluating PALI-2108, a once-daily oral PDE4 inhibitor prodrug designed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palisade-bio-announces-topline-data-from-pali-2108-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palisade-bio-announces-topline-data-from-pali-2108-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623732624","title":"Palisade Bio reports positive Phase 1b PALI-2108 data in fibrostenotic Crohn’s disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2623732624","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623732624?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:03","pubTimestamp":1774900986,"startTime":"0","endTime":"0","summary":"Palisade Bio reported positive topline Phase 1b results for oral Crohn’s disease candidate PALI-2108 in patients with fibrostenotic disease.Study signaled favorable safety and tolerability, with early evidence of improvement on endoscopic assessment.Data also supported once-daily dosing, with drug activity consistent with reduced inflammatory burden.Management will present topline findings in a webcast on March 31, 2026.Company plans to advance PALI-2108 into a Phase 2 trial in moderate to severe Crohn’s disease to evaluate clinical outcomes over 12 weeks.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL7Qfbcq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4139","SG9999014013.SGD","LU2095319765.USD","BK4585","SG9999014021.USD","LU0314104364.USD","BK4112","SG9999014005.SGD","LU2210150020.SGD","SG9999014039.USD","BK4007","IE00BN0W2W23.USD","NDAQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","PALI","BK4588","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623326417","title":"Palisade Bio Inc - Pali-2108 Shows Favorable Safety With No Serious Adverse Events After Two Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2623326417","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623326417?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:01","pubTimestamp":1774900860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA2JNGRF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","PALI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623326414","title":"Palisade Bio Inc - Phase 1B Data Show 47.5% Ses-Cd Reduction; 40% Endoscopic Response and Remission","url":"https://stock-news.laohu8.com/highlight/detail?id=2623326414","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623326414?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:01","pubTimestamp":1774900860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA2JNGRF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PALI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623264483","title":"Palisade Bio Inc - to Advance Pali-2108 Into Phase 2 Trial in Moderate to Severe Crohn's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2623264483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623264483?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:01","pubTimestamp":1774900860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA2JNGRF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","PALI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":69,"code":"91000000","status":"200"}]}}